Chris Key

Empowering Enterprise with Tech Innovation

📍 United States🔄 Updated September 2026💼 3 investments📅 11 years investing🗓 Last invested Dec 2022
Operator-angel🌍 United States
3
Total investments
3
Early stage
0
Mid stage
0
Late stage
11y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Enterprise Advisor / Investor
Dec 2022
Humans + InstaLILY = Superhuman Teams. AI teammates for complex sales, parts, and service workflows. Doing real work that demands judgment and domain expertise. InstaBrain™ is the intelligence layer: small, specialized language models that understand your parts, jobs, pricing rules, and workflows. InstaWorkers™ are the execution layer: AI teammates that use that intelligence to complete sales, service, and operations work directly inside your ERP, CRM, and service systems. Together, they form the AI-native infrastructure powering companies that move parts and run jobs.
Angel Investor
May 2015
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic. Cyrus is based on core software from the lab of David Baker at the University of Washington. We’ve worked with over 90 industry partners. We are based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria. We are hiring! https://cyrusbio.com/careers/
Angel Investor
Apr 2015
SightX is an A.I. powered consumer insights platform for insights, marketing, and product leaders. We empower our users to conduct competitive and customer research, transform insights into strategic plans and navigate the execution of those plans.
early stageMarket Research
Experience · 5 entries
All (5)
Investments (3)
Founder (1)
2024
Co-Founder / Enterprise GTM
Jan 2024
Organisations worldwide grapple with the menace of organisational fraud. Such frauds not only destroy shareholder value but also impact financial performance. However, the most damaging aspect of fraud is reputational damage, which affects growth and adversely impacts a companys ability to attract talent and capital providers. Despite significant regulatory and board-mandated efforts to combat this detrimental behavior, fraud incidences continues to grow globally. This is because fraud risk management is essentially a post-facto exercise, and most measures are retrospective than proactive. As per an ACFE study, over 95% of fraud incidences are identified after going undetected for an average of 9-12 months. Fortifai is on a mission to address this colossal need gap through its SaaS (“Software As A Service”) platform, which proactively and continuously monitors enterprise systems, identifying patterns and signals of fraudulent behavior. The Fortifai platform enables organisations to monitor, detect, investigate, and protect against potential fraud/regulatory risks. It has been designed from the ground up by Industry experts with deep domain expertise. Fortifai leverages AI to automate, enhance and fortify the fraud risk management procedures that functional experts use to manage risks today.
2022
Enterprise Advisor / Investor
Dec 2022
Humans + InstaLILY = Superhuman Teams. AI teammates for complex sales, parts, and service workflows. Doing real work that demands judgment and domain expertise. InstaBrain™ is the intelligence layer: small, specialized language models that understand your parts, jobs, pricing rules, and workflows. InstaWorkers™ are the execution layer: AI teammates that use that intelligence to complete sales, service, and operations work directly inside your ERP, CRM, and service systems. Together, they form the AI-native infrastructure powering companies that move parts and run jobs.
2021
Enterprise Client Partner
Oct 2021
Databook’s award-winning Strategic Relationship Management (SRM) platform uses advanced AI and NLP to empower the world’s largest B2B sales teams to create, manage, and maintain strategic relationships at scale. The platform ingests and interprets billions of financial and market data signals to generate actionable sales strategies that connect the seller’s solutions to a buyer’s financial pain and urgency. Find out more at www.databook.com
2015
Angel Investor
May 2015
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic. Cyrus is based on core software from the lab of David Baker at the University of Washington. We’ve worked with over 90 industry partners. We are based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria. We are hiring! https://cyrusbio.com/careers/
Angel Investor
Apr 2015
SightX is an A.I. powered consumer insights platform for insights, marketing, and product leaders. We empower our users to conduct competitive and customer research, transform insights into strategic plans and navigate the execution of those plans.
early stageMarket Research
Investment activity
2015–2022 · 3 investments
2015220221
Recent (last 2 years)Earlier